Hikma plc (Hikma’s) is one of 21st century growing pharmaceutical company founded in Jordan in 1978. Hikma’s mainly provides high-quality, affordable medicines to the people who need them.
The aim of this report is to analyse whether Hikma’s is worth giving loan of £50 million for 5 years at around 6% interest. Various ratios were taken into a consideration. All the used formulas and calculations are provided in the Appendix.
This report will pay particular attention to performance, liquidity, solvency, working capital and shareholder as well as ratios based on share price and will highlight major changes within the year 2015-2017. The main source for the analysis will be the companies Annual Reports. The investor then can evaluate all the important ratios during the last three years and decide whether to give loan to Hikma’s or not.